Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietin

Hoppensteadt, DATobu, MChatha, MBansal, VMoghaddam, MSaxena, RAhmad, S2024-06-122024-06-1220040009-9147https://hdl.handle.net/20.500.14551/2670656th Annual Meeting of the American-Association-for-Clinical-Chemistry -- JUL 25-29, 2004 -- Los Angeles, CA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Prevalence and pathogenic role of anti-EPO antibodies in patients treated with recombinant erythropoietinConference Object506A54A54Q1WOS:000221955200174